Tumor-induced endothelial cell activation: Role of vascular endothelial growth factor

American Journal of Physiology - Cell Physiology

Volumn 286, Issue 5 55-5, 2004, Pages

  Castilla, M Ángeles ^a,c   Neria, Fernando ^a,c   Renedo, Guadalupe ^a   Pereira, Daniel S ^d   González Pacheco, Francisco R ^a,c   Jiménez, Sonsoles ^a   Tramón, Paloma ^a   Deudero, J J P ^a   Alvarez Arroyo, M V ^a,c   Yagüe, Susana ^a,c   Caramelo, Carlos ^a,b,c  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c Instituto Reina Sofia de Investigaciones Nefrologicas   (Spain)

^d ELI LILLY AND COMPANY   (United States)

Author keywords

MG63 conditioned medium; Vascular endothelial growth factor receptor 2

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; BLOOD CLOTTING FACTOR 8; COBALT CHLORIDE; MATRIGEL; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL CELL; AORTA; ARTICLE; CATTLE; CELL ACTIVATION; CELL PROLIFERATION; CELL PROTECTION; CELL SURVIVAL; CHROMATIN CONDENSATION; CONTROLLED STUDY; CYTOSOL; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOLUS; OSTEOBLAST; OSTEOSARCOMA CELL; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; VASCULAR ENDOTHELIUM;

ANIMALS; AORTA; CATTLE; CELL LINE, TUMOR; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; ENDOTHELIUM, VASCULAR; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASMS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

ANIMALIA; BOS TAURUS; BOVINAE;

EID: 11144355228     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.00306.2003     Document Type: Article

References (25)

1. Alvarez-Arroyo MV, Yague S, Wenger RM, Pereira DS, Jimenez S, Gonzalez-Pacheco FR, Castilla MA, Deudero JJP, and Caramelo C. Cyclophilin-mediated pathways in the effect of cyclosporin A on endothelial cells: role of vascular endothelial growth factor. Circ Res 91: 202-209, 2002.
2. Benjamin LE, Golijanin D, Itin A, Pode D, and Keshet E. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J Clin Invest 103: 159-165, 1999.
3. Benjamin LE and Keshet E. Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc Natl Acad Sci USA 94: 8761-8766, 1997.
4. Brekken RA, Huang X, King SW, and Thorpe PE. Vascular endothelial growth factor as a marker of tumor endothelium. Cancer Res 58: 1952-1959, 1998.
5. Brekken RA, Overholser JP, Stastny VA, Waltenberger J, Minna JD, and Thorpe PE. Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice. Cancer Res 60: 5117-5124, 2000.
6. Cai J, Jiang WG, and Mansel RE. Phosphorylation and disorganization of vascular-endothelial cadherin in interaction between breast cancer and vascular endothelial cells. Int J Mol Med 4: 191-195, 1999.
7. Castilla MA, Arroyo MV, Aceituno E, Aragoncillo P, Gonzalez-Pacheco FR, Texeiro E, Bragado R, and Caramelo C. Disruption of cadherin-related junctions triggers autocrine expression of vascular endothelial growth factor in bovine aortic endothelial cells: efffects on cell proliferation and death resistance. Circ Res 85: 1132-1138, 1999.
8. Castilla MA, Caramelo C, Gazapo RM, Martin O, Gonzalez-Pacheco FR, Tejedor A, Bragado R, and Alvarez Arroyo MV. Role of vascular endothelial growth factor (VEGF) in endothelial cell protection against cytotoxic agents. Life Sci 67: 1003-1013, 2000.
9. Chan AS, Leung SY, Wong MP, Yuen ST, Cheung N, Fan YW, and Chung LP. Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma oligodendroglioma, and ependymoma. Am J Surg Pathol 22: 816-826, 1998.
10. Chavakis E and Dimmeler S. Regulation of endothelial cell survival and apoptosis during angiogenesis. Arterioscler Thromb Vasc Biol 22: 887-893, 2002.
11. Drevs J, Hofmann I, Hugenschmidt H, Wittig C, Madjar H, Muller M, Wood J, Martiny-Baron G, Unger C, and Marme D. Effects of PTK787/ZK 222584, a specific inhibitor of vascular endothelial growth factor receptor tyrosine kinases, on primary tumor, metastasis, vessel density, and blood flow in a murine renal cell carcinoma model. Cancer Res 60: 4819-4824, 2000.
12. Ferrara N. VEGF: an update on biological and therapeutic aspects. Curr Opin Biotechnol 11: 617-624, 2000.
13. Ferrara N. Vascular endothelial growth factor and the regulation of angiogenesis. Recent Prog Horm Res 55: 15-35, 2000.
14. Folkman J and Haudenschild C. Angiogenesis in vitro. Nature 288: 551-556, 1980.
15. Folkman J, Haudenschild C, and Zetter BR. Long-term culture of capillary endothelial cells. Proc Natl Acad Sci USA 76: 5217-5221, 1979.
16. Fong TA, Shawver LK, Sun L, Tang C, App H, Powell TJ, Kim YH, Schreck R, Wang X, Risau W, Ullrich A, Hirth KP, and McMahon G. SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types. Cancer Res 59: 99-106, 1999.
17. Hatva E, Bohling T, Jaaskelainen J, Persico MG, Halita M, and Alitalo K. Vascular growth factors and receptors in capillary hemangioblastomas and hemangiopericytomas. Am J Pathol 148: 763-775, 1996.
18. Kranz A, Mattfeldt T, and Waltenberger J. Molecular mediators of tumor angiogenesis: enhanced expression and activation of vascular endothelial growth factor receptor KDR in primary breast cancer. Int J Cancer 84: 293-298, 1999.
19. Lopez Farre A, Riesco A, Espinosa G, Digiuni E, Cernadas MR, Alvarez V, Monton M, Rivas F, Gallego MJ, Egido J, and Caramelo C. Effect of endothelin-1 on neutrophil adhesion to endothelial cells and perfused heart. Circulation 88: 1166-1171, 1993.
20. Monton M, Castilla MA, Alvarez Arroyo MV, Tan D, Gonzalez-Pacheco FR, Lopez Farre A, Casado S, and Caramelo C. Effects of angiotensin II on endothelial cell growth: role of AT-1 and AT-2 receptors. J Am Soc Nephrol 9: 969-974, 1998.
21. Ortega N, Jonca F, Vincent S, Favard C, Ruchoux MM, and Plouet J. Systemic activation of the vascular endothelial growth factor receptor KDR/ flk-1 selectively triggers endothelial cells with an angiogenic phenotype. Am J Pathol 151: 1215-1224, 1997.
22. Papetti M and Herman IM. Mechanisms of normal and tumor-derived angiogenesis. Am J Physiol Cell Physiol 282: C947-C970, 2002.
23. Shiojima I and Walsh K. Role of Akt signaling in vascular homeostasis and angiogenesis. Circ Res 90: 1243-1250, 2002.
24. Wang D, Donner DB, and Warren RS. Homeostatic modulation of cell surface KDR and Flt1 expression and expression of the vascular endothelial cell growth factor (VEGF) receptor mRNAs by VEGF. J Biol Chem 275: 15905-15911, 2000.
25. Wood JM, Bold G, Buchdunger E, Cozens R, Ferrari S, Frei J, Hofmann F, Mestan J, Mett H, O'Reilly T, Persohn E, Rosel J, Schnell C, Stover D, Theuer A, Towbin H, Wenger F, Woods-Cook K, Menrad A, Siemeister G, Schirner M, Thierauch KH, Schneider MR, Drevs J, Martiny-Baron G, and Totzke F. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration. Cancer Res 60: 2178-2189, 2000.